If you would like to receive more information on organising a corporate session or presentation at ESHG 2025 , please contact: Ms. Jantie de Roos at Rose INTERNATIONAL.
Saturday, May 24, 2025 – 10.00 – 11.15 CEST
Saturday, May 24, 2025 – 12.15 – 13.30 CEST
Empowering Precision Medicine: The power of WES, mitochondrial analysis, WGS and screening
Redefining Tumor Profiling: An Innovative, Non-Invasive Approach to cfDNA Biomarker Integration from Plasma and Urine Using Advanced Bioinformatics
Applied innovation in genomics: Enhanced exome and hereditary cancer end-to-end solutions
Sunday, May 25, 2025 – 08.30 – 10.00 CEST
Sunday, May 25, 2025 – 12.00 – 13.00 CEST
Enhancing rare disease research through automated workflows for genomic variant detection
Precision Screening for Inherited Disorders: Novel Approach Tackling Complex Variants in challenging Genes with Nanopore Sequencing
Scalable Technology Platform for Genetic Testing: CE-marked and IVDR Solutions with Optimized Workflows to Maximize Efficiency
From Pilot to Breakthroughs: Insights from the UK Biobank Pharma Proteomics Project and what’s next for proteomics
Sunday, May 25, 2025 – 12.15 – 12.45 CEST
Sunday, May 25, 2025 – 13.00 – 13.30 CEST
Genetic Innovation: Exploring IVDR-Compliant Sanger Sequencing for Enhanced Diagnostics
Sunday, May 25, 2025 – 14.15– 15.45 CEST
Enabling rare disease research with rapid workflows by SBX technology and the AVENIO Edge automated KAPA HyperExome V2 solution
Monday, May 26, 2025 – 12.00 – 13.00 CEST
Redefining Single Cell RNA Sequencing Limits with Evercode™ Combinatorial Barcoding
Monday, May 26, 2024 – 12.15 – 12.45 CEST
Innovative Breakthroughs in Pharmacogenetic Testing: Pioneering the Future of Precision Medicine
Monday, May 26, 2024 – 14.15 – 15.45 CEST
Unlocking discovery via one of the world’s largest rare disease and cancer whole genome sequencing datasets